Evonik ramps up production capacity for biomaterials
ESSEN, GERMANY -- Evonik is expanding its production facilities in Birmingham (Alabama, USA) and Darmstadt (Germany). This will create additional capacity for the production of biodegradable polymers marketed globally under the brand names RESOMER and RESOMER SELECT. These poly-lactic-glycolic-acid (PLGA) copolymers are primarily used to manufacture bioresorbable medical devices and controlled-release formulations for parenteral drug delivery.
"We expect the global demand for biodegradable polymers to continue to grow in the coming years," said Paul Spencer, Head of Biomaterials at Evonik’s Health Care Business Line. "With this in mind, we are currently investing to increase the capacity of our production facilities in order to serve our global customer base."
The expansion will involve construction of a new building adjacent to Evonik’s existing facility in Birmingham. Commissioning is slated for late 2018.
Comments